Analystreport

Kala Pharmaceuticals, Inc. (NASDAQ: KALA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Kala Pharmaceuticals, Inc.  (KALA) 
Last kala pharmaceuticals, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com